Product Information
NORLIQVA 1 MG/ML SOLUTION is a brand product labeled by CMP Pharma, Inc., priced at $3.2172 per ML under NDC 46287003515. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Feb 24, 2022.
Strength
1 mg/mL
Manufacturer
CMP Pharma, Inc.NDC
46287003515
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINEApproval Type
New Drug (NDA)
FDA Application
NDA214439FDA Approved
2/24/2022
On Market Since
4/15/2022
Pharmacological Classes
Price Statistics
The NADAC for NORLIQVA 1 MG/ML SOLUTION has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2172 per ML |
|---|---|
| All-time high | $3.3007 (Oct 15, 2025) |
| All-time low | $3.1829 (Mar 18, 2026) |
| 52-week high | $3.3007 |
| 52-week low | $3.1829 |
| Median price | $3.2778 |
| Average price | $3.2569 |
| Largest weekly change | +2.5% (Nov 20, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CMP Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORLIQVA 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for NORLIQVA 1 MG/ML SOLUTION, manufactured by CMP Pharma, Inc., is $3.2172 per ML (NDC 46287003515), effective Sep 30, 2026.
How has the price of NORLIQVA 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for NORLIQVA 1 MG/ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NORLIQVA 1 MG/ML SOLUTION?
Since Apr 17, 2024, the NADAC for NORLIQVA 1 MG/ML SOLUTION has ranged from a low of $3.1829 (Mar 18, 2026) to a high of $3.3007 (Oct 15, 2025), with a median of $3.2778 per ML.
Are there cheaper alternatives to NORLIQVA 1 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of NORLIQVA 1 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NORLIQVA 1 MG/ML SOLUTION?
NORLIQVA 1 MG/ML SOLUTION (NDC 46287003515) is labeled by CMP Pharma, Inc., and CMS classifies it as a brand product.